The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation

Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications

(2011) Maria Carmela Vegliante et al.   PLoS One

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

(2010) V. Fernandez et al.   CANCER RESEARCH

Molecular characterization of ovarian cancer by gene-expression profiling

(2010) C. Gómez-Raposo et al.   GYNECOLOGIC ONCOLOGY

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

(2010) Helen J. Mackay et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

(2010) Åsa Ehlén et al.   Journal of Translational Medicine

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies

(2010) Elin Gustavsson et al.   Molecular Cancer

Sox11 Is Expressed in Early Progenitor Human Multipotent Stromal Cells and Decreases with Extensive Expansion of the Cells

(2010) Benjamin L. Larson et al.   TISSUE ENGINEERING PART A

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

(2010) Björn Nodin et al.   Journal of Ovarian Research

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

(2009) A. Berchuck et al.   CLINICAL CANCER RESEARCH

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

(2009) Donal J. Brennan et al.   EUROPEAN JOURNAL OF CANCER

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer

(2009) Daniela E. Matei et al.   GYNECOLOGIC ONCOLOGY

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma

(2009) M. Dictor et al.   HAEMATOLOGICA

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

(2009) A. Mozos et al.   HAEMATOLOGICA

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms

(2009) Yi-Hua Chen et al.   MODERN PATHOLOGY

Precursors of endometrial and ovarian carcinoma

(2009) Robert J. Kurman et al.   VIRCHOWS ARCHIV

The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival

(2008) Xiao Wang et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

(2008) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

(2008) C. Blake Gilks et al.   HUMAN PATHOLOGY

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

(2008) Charles N. Landen et al.   JOURNAL OF CLINICAL ONCOLOGY

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

(2007) S. Ek et al.   BLOOD